Zhejiang Tianhuang Medicine

Zhejiang Tianhuang Pharmaceutical is a leading Chinese enterprise specializing in the development and commercialization of Traditional Chinese Medicine (TCM), particularly products derived from Dendrobium officinale (Tiepi Shihu). The company is widely recognized for pioneering the large-scale artificial cultivation of this rare medicinal herb, which was previously near extinction in the wild. Its flagship brand, Li Zuan, holds a significant market share in China for Tiepi Fengdou granules and capsules. The company maintains a vertically integrated business model that includes GAP-certified cultivation bases, advanced extraction facilities, and a nationwide distribution network. Its products are primarily marketed for immune system support, fatigue recovery, and the management of chronic ailments within the TCM therapeutic framework.